Javelin Pharmaceuticals CEO buys shares

By Associated Press
June 27, 2008 | Comments (0)

Recs

0

Panic 2008... Profit 2009!

Fool -- Now's the time to invest! David and Tom Gardner's new book reveals their strategy for million dollar wealth.

Buy Now!

The chief executive of drug developer Javelin Pharmaceuticals Inc. bought 30,000 shares of stock, according to a Securities and Exchange Commission filing Thursday.

In a Form 4 filed with the SEC, Martin J. Driscoll reported buying the shares for $2.32 apiece on Thursday.

Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.

Javelin Pharmaceuticals is based in Cambridge, Mass.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

DocumentId: 674730, ~/articles/articlehandler.aspx, 1/8/2009 4:28:28 AM

Sign up for FREE Motley Fool site access to keep reading:

“Javelin Pharmaceuticals CEO buys shares”

Signing up allows you to comment on articles and on the discussion boards.

It's completely FREE and will take only 10 seconds.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.